Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Miklos Rohla

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
American Journal of Physiology. Heart and Circulatory Physiology|September 6, 2024
Intracoronary ECG ST-segment shift remission time during reactive myocardial hyperemia: a new method to assess hemodynamic coronary stenosis severityMarius Reto Bigler, Andrea Kieninger-Gräfitsch, Miklos Rohla, et al.
Atherosclerosis|February 13, 2018
Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary interventionMaximilian Tscharre, Robert Herman, Miklos Rohla, et al.
Journal of Clinical Lipidology|October 23, 2018
Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary interventionMaximilian Tscharre, Robert Herman, Miklos Rohla, et al.
The American Journal of Medicine|January 22, 2019
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial FibrillationGiuseppe Patti, Ladislav Pecen, Markus Lucerna, et al.
Thrombosis and Haemostasis|December 29, 2018
Prognostic Impact of Soluble P-Selectin on Long-Term Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary InterventionMaximilian Tscharre, Birgit Vogel, Ioannis Tentzeris, et al.
Thrombosis and Haemostasis|February 24, 2017
Platelet turnover predicts outcome after coronary interventionMatthias K Freynhofer, Liana Iliev, Veronika Bruno, et al.
European Heart Journal. Acute Cardiovascular Care|March 4, 2016
Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarctionBarbara Fellner, Miklos Rohla, Rudolf Jarai, et al.
Circulation. Cardiovascular Quality and Outcomes|June 3, 2021
Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation RegistriesMiklos Rohla, Ladislav Pecen, Roberto Cemin, et al.
Wiener Klinische Wochenschrift|October 24, 2023
Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary interventionAchim Leo Burger, Nora Beran, Edita Pogran, et al.
International Journal of Cardiology|June 24, 2020
Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategiesGiuseppe Patti, Ladislav Pecen, Marius Constantin Manu, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
American Journal of Physiology. Heart and Circulatory Physiology|September 6, 2024
Intracoronary ECG ST-segment shift remission time during reactive myocardial hyperemia: a new method to assess hemodynamic coronary stenosis severityMarius Reto Bigler, Andrea Kieninger-Gräfitsch, Miklos Rohla, et al.
Atherosclerosis|February 13, 2018
Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary interventionMaximilian Tscharre, Robert Herman, Miklos Rohla, et al.
Journal of Clinical Lipidology|October 23, 2018
Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary interventionMaximilian Tscharre, Robert Herman, Miklos Rohla, et al.
The American Journal of Medicine|January 22, 2019
Net Clinical Benefit of Non-Vitamin K Antagonist vs Vitamin K Antagonist Anticoagulants in Elderly Patients with Atrial FibrillationGiuseppe Patti, Ladislav Pecen, Markus Lucerna, et al.
Thrombosis and Haemostasis|December 29, 2018
Prognostic Impact of Soluble P-Selectin on Long-Term Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary InterventionMaximilian Tscharre, Birgit Vogel, Ioannis Tentzeris, et al.
Thrombosis and Haemostasis|February 24, 2017
Platelet turnover predicts outcome after coronary interventionMatthias K Freynhofer, Liana Iliev, Veronika Bruno, et al.
European Heart Journal. Acute Cardiovascular Care|March 4, 2016
Activated protein C levels and outcome in patients with cardiogenic shock complicating acute myocardial infarctionBarbara Fellner, Miklos Rohla, Rudolf Jarai, et al.
Circulation. Cardiovascular Quality and Outcomes|June 3, 2021
Reclassification, Thromboembolic, and Major Bleeding Outcomes Using Different Estimates of Renal Function in Anticoagulated Patients With Atrial Fibrillation: Insights From the PREFER-in-AF and PREFER-in-AF Prolongation RegistriesMiklos Rohla, Ladislav Pecen, Roberto Cemin, et al.
Wiener Klinische Wochenschrift|October 24, 2023
Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary interventionAchim Leo Burger, Nora Beran, Edita Pogran, et al.
International Journal of Cardiology|June 24, 2020
Thromboembolic and bleeding risk in obese patients with atrial fibrillation according to different anticoagulation strategiesGiuseppe Patti, Ladislav Pecen, Marius Constantin Manu, et al.
Pageof 5